# Clinical Study Spartan COVID-19 V2 System (Canada Alternate)

> **NCT04628208** · — · COMPLETED · sponsor: **Spartan Bioscience Inc.** · enrollment: 81 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Spartan COVID-19 v2 System

## Key facts

- **NCT ID:** NCT04628208
- **Lead sponsor:** Spartan Bioscience Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-17
- **Primary completion:** 2020-12-07
- **Final completion:** 2020-12-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04628208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04628208, "Clinical Study Spartan COVID-19 V2 System (Canada Alternate)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04628208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*